Carboplatin Drug Interactions: What to Avoid and What to Tell Your Doctor

Before starting carboplatin treatment, it is essential that your oncologist and pharmacist have a complete list of every medication, supplement, and over-the-counter drug you take. Carboplatin has important interactions with several drug classes that can increase toxicity, reduce effectiveness, or create dangerous complications. This guide covers the most clinically significant interactions.

Why Drug Interactions with Carboplatin Matter

Carboplatin's main risks involve bone marrow suppression (especially low platelets) and kidney toxicity. Many drug interactions amplify one or both of these risks. Some interactions reduce the levels of other drugs in your body (potentially making other medications ineffective). And because carboplatin is a hazardous chemotherapy agent, even moderate interactions can have serious clinical consequences.

Major Interactions: Avoid or Use Alternative

Aminoglycoside antibiotics (gentamicin, tobramycin, amikacin): Combined use significantly increases both kidney damage (nephrotoxicity) and hearing loss (ototoxicity). If you need antibiotic treatment while on carboplatin, your care team should use a non-aminoglycoside antibiotic whenever possible.

Palifermin (Kepivance): Must not be given within 24 hours before, during, or after carboplatin infusion. Concurrent use with chemotherapy increases the severity and duration of oral mucositis (mouth sores).

Other myelosuppressive agents: Drugs that suppress bone marrow (including many other chemotherapy agents, some biologic therapies, and myelosuppressive immunosuppressants like tofacitinib) have additive effects with carboplatin, increasing the risk of dangerously low blood counts.

Live vaccines: Do not receive live vaccines (such as the live oral polio vaccine, varicella, or yellow fever) during carboplatin treatment or shortly after. Carboplatin suppresses the immune system, and live vaccines can cause serious infection in immunocompromised patients.

Moderate Interactions: Use with Caution and Monitor Closely

Phenytoin (Dilantin) and other anticonvulsants: Carboplatin can decrease phenytoin blood levels by an unknown mechanism, potentially reducing seizure control. If you take phenytoin, your neurologist and oncologist need to monitor your phenytoin levels carefully during carboplatin treatment and after completion.

Vancomycin: Concurrent use increases kidney toxicity risk. If you need vancomycin during carboplatin treatment, your team should closely monitor kidney function and vancomycin drug levels.

Nephrotoxic drugs (NSAIDs, certain contrast agents, acyclovir): Any drug that affects kidney function can potentiate carboplatin's effects by impairing its clearance. This includes non-steroidal anti-inflammatory drugs (ibuprofen, naproxen), contrast dye used in CT scans, and antiviral medications with renal effects.

Trastuzumab (Herceptin) and antibody drug conjugates: Combined use with HER2-targeting therapies increases myelosuppression risk. Increased incidence of neutropenia and febrile neutropenia has been observed when these agents are combined with myelosuppressive chemotherapy including carboplatin.

Pentamidine and paromomycin: Both increase nephrotoxicity and ototoxicity when used with carboplatin. Use with caution and monitor renal function closely.

Important Technical Note: No Aluminum in IV Lines

This is not a drug interaction per se, but it is critical: aluminum reacts with carboplatin to form a precipitate that destroys the drug's potency. Needles, IV sets, or catheter components containing aluminum must never come in contact with carboplatin solution during preparation or administration. This is an important quality control point for your infusion center's pharmacy team.

Supplements and OTC Medications to Discuss

While vitamin A and other antioxidants have been studied in the context of chemotherapy (with some evidence they may enhance efficacy and reduce toxicity), the evidence is not conclusive. Do not take any vitamins, minerals, herbal supplements, or over-the-counter medications without first discussing them with your oncology team — some antioxidants may interfere with chemotherapy's intended mechanism.

What to Tell Your Oncologist Before Your First Infusion

All prescription medications (including seizure meds, heart medications, blood thinners, antibiotics)

All over-the-counter drugs including NSAIDs (ibuprofen, aspirin, naproxen)

All vitamins, supplements, and herbal products

Any upcoming procedures that might require IV contrast dye (CT scans with contrast)

Any planned vaccinations (live vaccines should not be given during treatment)

Understanding interactions is part of managing carboplatin safety. See our companion guide on carboplatin side effects for a full picture of what to expect during treatment.